BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 33146791)

  • 1. Individualized nomogram for predicting ALK rearrangement status in lung adenocarcinoma patients.
    Song L; Zhu Z; Wu H; Han W; Cheng X; Li J; Du H; Lei J; Sui X; Song W; Jin ZY
    Eur Radiol; 2021 Apr; 31(4):2034-2047. PubMed ID: 33146791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of imaging biomarkers in predicting anaplastic lymphoma kinase-positive lung adenocarcinoma.
    Jeong CJ; Lee HY; Han J; Jeong JY; Lee KS; Choi YL; Choi JY
    Clin Nucl Med; 2015 Jan; 40(1):e34-9. PubMed ID: 25243942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Semiquantitative parameters of
    Liao XH; Wang RF; Liu M; Chen XQ; Xiong Y; Nong L; Yin L; Zhang BY; DU YJ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Oct; 53(2):246-254. PubMed ID: 33879893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and CT characteristics of surgically resected lung adenocarcinomas harboring ALK rearrangements or EGFR mutations.
    Wang H; Schabath MB; Liu Y; Han Y; Li Q; Gillies RJ; Ye Z
    Eur J Radiol; 2016 Nov; 85(11):1934-1940. PubMed ID: 27776643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of
    Lv Z; Fan J; Xu J; Wu F; Huang Q; Guo M; Liao T; Liu S; Lan X; Liao S; Geng W; Jin Y
    Eur J Nucl Med Mol Imaging; 2018 May; 45(5):735-750. PubMed ID: 29164298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced adenocarcinoma of the lung: comparison of CT characteristics of patients with anaplastic lymphoma kinase gene rearrangement and those with epidermal growth factor receptor mutation.
    Choi CM; Kim MY; Hwang HJ; Lee JB; Kim WS
    Radiology; 2015 Apr; 275(1):272-9. PubMed ID: 25575117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative CT features for prediction of ALK gene rearrangement in lung adenocarcinomas.
    Wang H; Wang Y; Zhang H; Han Y; Li Q; Ye Z
    Clin Radiol; 2020 Jul; 75(7):562.e21-562.e29. PubMed ID: 32307109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivariate analysis based on the maximum standard unit value of
    Wang Y; Lyu D; Zhou T; Tu W; Fan L; Liu S
    Diagn Interv Radiol; 2023 Mar; 29(2):379-389. PubMed ID: 36988049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative analysis of clinicoradiologic characteristics of lung adenocarcinomas with ALK rearrangements or EGFR mutations.
    Zhou JY; Zheng J; Yu ZF; Xiao WB; Zhao J; Sun K; Wang B; Chen X; Jiang LN; Ding W; Zhou JY
    Eur Radiol; 2015 May; 25(5):1257-66. PubMed ID: 25577516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there imaging characteristics associated with lung adenocarcinomas harboring ALK rearrangements?
    Halpenny DF; Riely GJ; Hayes S; Yu H; Zheng J; Moskowitz CS; Ginsberg MS
    Lung Cancer; 2014 Nov; 86(2):190-4. PubMed ID: 25312988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
    Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
    Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between EGFR, ALK Gene Mutation and Imaging 
and Pathological Features in Invasive Lung Adenocarcinoma].
    Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Additional value of metabolic parameters to PET/CT-based radiomics nomogram in predicting lymphovascular invasion and outcome in lung adenocarcinoma.
    Nie P; Yang G; Wang N; Yan L; Miao W; Duan Y; Wang Y; Gong A; Zhao Y; Wu J; Zhang C; Wang M; Cui J; Yu M; Li D; Sun Y; Wang Y; Wang Z
    Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):217-230. PubMed ID: 32451603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of anaplastic lymphoma kinase rearrangement in early-stage lung cancer: Analysis of a nationwide Japanese database.
    Matsuura Y; Mun M; Shintani Y; Okami J; Ito H; Ohtsuka T; Mori T; Watanabe SI; Chida M; Endo S; Nakanishi R; Kadokura M; Suzuki H; Miyaoka E; Yoshino I; Date H;
    J Surg Oncol; 2023 Oct; 128(5):916-924. PubMed ID: 37403534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangements in lung cancer with nodular ground-glass opacity.
    Ko SJ; Lee YJ; Park JS; Cho YJ; Yoon HI; Chung JH; Kim TJ; Lee KW; Kim K; Jheon S; Kim H; Lee JH; Lee CT
    BMC Cancer; 2014 May; 14():312. PubMed ID: 24885886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A clinically practical radiomics-clinical combined model based on PET/CT data and nomogram predicts EGFR mutation in lung adenocarcinoma.
    Chang C; Zhou S; Yu H; Zhao W; Ge Y; Duan S; Wang R; Qian X; Lei B; Wang L; Liu L; Ruan M; Yan H; Sun X; Xie W
    Eur Radiol; 2021 Aug; 31(8):6259-6268. PubMed ID: 33544167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, Conventional CT and Radiomic Feature-Based Machine Learning Models for Predicting ALK Rearrangement Status in Lung Adenocarcinoma Patients.
    Song L; Zhu Z; Mao L; Li X; Han W; Du H; Wu H; Song W; Jin Z
    Front Oncol; 2020; 10():369. PubMed ID: 32266148
    [No Abstract]   [Full Text] [Related]  

  • 18. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
    Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
    Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Machine Learning Model Based on PET/CT Radiomics and Clinical Characteristics Predicts ALK Rearrangement Status in Lung Adenocarcinoma.
    Chang C; Sun X; Wang G; Yu H; Zhao W; Ge Y; Duan S; Qian X; Wang R; Lei B; Wang L; Liu L; Ruan M; Yan H; Liu C; Chen J; Xie W
    Front Oncol; 2021; 11():603882. PubMed ID: 33738250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT radiomics-based prediction of anaplastic lymphoma kinase and epidermal growth factor receptor mutations in lung adenocarcinoma.
    Choe J; Lee SM; Kim W; Do KH; Kim S; Choi S; Seo JB
    Eur J Radiol; 2021 Jun; 139():109710. PubMed ID: 33862316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.